The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Roses are red, inflation is too...

Tue, 14th Feb 2023 12:25

STOXX 600 up 0.6%

*

Wall St futures higher

*

Telecoms sector leads

*

Eyes on U.S. CPI

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at

ROSES ARE RED, INFLATION IS TOO... (1216 GMT)

The Fed's watching services... to see when it's through. If you're looking for a thorough review ahead of today's Valentine's CPI print, then you could do worse than read the above link. If you're looking for what it might mean for markets, read on.

The Fed's data-dependent approach has meant the markets have had a love affair with CPI data over the last year, with equities, bonds and currencies all seeing outsized price swings on CPI day.

"Only two of the past 12 monthly reports have been in-line with forecasts," eToro global markets strategist Ben Laidler notes. "This saw an average 1.9% S&P 500 and 1.3% STOXX 600 'inflation day' price swing."

Jefferies interest rate strategist Mohit Kumar highlights that Tuesday's print has "added complexity" given large seasonal adjustments and weights, with market bias seemingly for an "upward surprise".

"Hence, an inline print would be seen as a relief for fixed income and risky assets," Kumar says.

"Given the difficulty in predicting inflation in recent months, we would focus on the expected market reaction rather than on predicting the number."

And finally, from Barclays on the sheer magnitude of today's data.

"This week's US CPI is one of the most pivotal prints in recent memory," analysts at the bank said in a note released on Sunday.

"In the absence of accelerating inflation, accelerating growth is positive for risky assets and negative for the USD," Barclays said.

"A strong number, on the other hand, would obviously favor Fed hawks for a while."

Economists polled by Reuters expect headline annual inflation to slow to 6.2%, with the core reading slowing to 5.5% from 5.7%.

BRITAIN'S TRAVEL STOCKS TAKE OFF (1127 GMT)

Tuesday has been another strong day for London-listed travel stocks. A double-upgrade for easyJet and an upbeat trading update from TUI has pushed the sector back towards an 11-month high hit earlier this month.

TUI, dual-listed in London and Frankfurt, said it was seeing a positive travel recovery trend for the summer season, despite market worries that inflationary pressures might dampen demand for travel.

"There doesn't seem to be any doubt about the lasting appeal of an escape away on holiday," says AJ Bell investment director Russ Mould, "something which has arguably been strengthened by the pandemic."

For easyJet, Deutsche Bank equity analyst Jaime Rowbotham has flipped positive on the name.

"The UK economic outlook has 'improved dramatically' according to our colleague Sanjay Raja," Rowbotham writes.

"We see this as positive for easyJet, the airline we cover which we think has greatest exposure to the UK."

Rowbotham notes that around 40% of easyJet's pre-COVID profit was from the UK and so upgrades the shares from a 'Sell' rating to 'Buy', propelling shares 4% higher on the day.

The helped push the FTSE 350 travel and leisure index up 0.9%, heading back towards its highest level since February last year, after around a 35% jump from its October low.

O CONSUMER! MY CONSUMER! PERSONAL SAVINGS NOT DOWN YET (1113 GMT)

How much of the 'excess' personal savings of U.S. consumers remain, following high inflation, interest rate hikes and rising lay-offs?

Citigroup says the personal savings, the trajectory of which shapes the outlook for consumption and economic growth, may be larger than the current estimate of the U.S. central bank staff - which is in the range of $1.2 trillion.

U.S. consumers were flush with savings during the pandemic and those are currently being drawn down due to higher borrowing costs and inflation.

The U.S. Federal Reserve's estimate of excess savings is "likely a floor rather than a ceiling," says the brokerage in a note dated February 13.

A prominent paper from the Fed's staff estimates an average expected saving rate of around 8.7% in this cycle (since 2020) and a current saving rate near 9%.

Even modest adjustments to the Fed paper assumptions about saving behavior can raise the Fed's estimate by several hundred billion dollars, says Citi.

The brokerage adds consumers' balance sheets are more healthy and, "at a minimum their current state should help buffer the economy during a downturn."

STOXX 600 UP ON TELECOMS BOOST, BUT TECH FALTERS (0910 GMT)

European stocks are faring better than futures indicated before the open, with the STOXX 600 last up 0.4%.

Astrazeneca, Nestle and TotalEnergies are providing the biggest boost to the index on an index net points weighted basis.

Telecoms are up 1.6%, pushed higher as Vodafone shares tick up 3.9% after news that Liberty Global bought a 5% stake in the British telecoms operator.

Travel names are also doing well after positive signals from holiday group TUI about the outlook for summer.

Meanwhile interest-rate sensitive tech names is the only sector slipping slightly into negative territory this morning, down 0.04%.

DON'T BREAK MY HEART (0755 GMT)

Today's inflation numbers from the world's biggest economy on Valentine's Day will be one of the most important economic data watched by markets.

While blockbuster January jobs data has forced some market participants to grudgingly accept that the peak is not yet near for interest rates, investors are still hopeful that the Federal Reserve could begin cutting rates later this year.

As Toronto-based independent proprietary trader Kevin Muir said: "I don't know if it will be this release or the next one, but I suspect the market has accepted the return to inflation normalcy a little too eagerly."

"There appears to be little fear about a lingering inflation problem. Sure, there are a few pundits warning about inflation, but the market is clearly screaming at the top of its lungs that inflation worries are misplaced."

The market expects rate increases to ease despite Fed Chair Jerome Powell acknowledging last week that rates may need to move higher than expected if that sort of economic strength threatens the Fed's progress in lowering inflation.

Economists polled by Reuters expect Tuesday's CPI reading to show headline prices and the core CPI gaining 0.5% and 0.4% month-over-month for January, respectively. However, some recalibrated their expectations on Monday for a slightly lower CPI.

Asian shares edged up on Tuesday, while the yen recouped losses as Japan nominated a new central bank governor.

Adding to the positive momentum, sources said that U.S. Secretary of State Antony Blinken is considering meeting top Chinese diplomat Wang Yi at the Munich Security Conference starting this week.

This would mark their first face-to-face talks after the United States shot down what it said was a Chinese spy balloon and other flying objects.

Meanwhile, the deep freeze over UK assets is thawing.

After last year's upheaval, Britain's stocks and bonds are drawing strong investor interest, with the FTSE 100 stock index flirting with record highs as the bourse benefits from global trends such as the reopening of China's economy and strong energy prices.

Ten-year government bond yields have fallen 27 basis points so far in 2023 to 3.4% in one of the biggest declines in government financing rates among the Group of Seven most advanced economies.

A Reuters poll published on Tuesday showed that the Bank of England will make its final increase to borrowing costs in the current cycle next month to combat double-digit inflation, while the economy is almost certainly entering a recession.

In Italy, Prime Minister Giorgia Meloni and her coalition allies scored emphatic election wins in the two wealthiest regions of the country, strengthening the right's grip on power.

Meanwhile, Qatari investors are preparing to make a bid to buy Premier League club Manchester United in the coming days, Bloomberg reported.

Key developments that could influence markets on Tuesday:

European economic data: Euro zone flash Q4 GDP, UK Dec jobs, Jan unemployment count

U.S. CPI data due: Jan CPI - core CPI forecast at +0.4% from +0.3% in Dec, +5.5% year-on-year from +5.7%

EUROPEAN FUTURES EDGE UP AHEAD OF U.S. CPI (0742 GMT)

Has the market been too optimistic about the rate of inflation as of late?

We should have at least a semblance of an answer later today, when U.S. CPI figures land. Perhaps understandably, European futures are making tentative moves higher this morning.

STOXX futures, DAX futures and FTSE futures are all up about 0.1%while U.S. futures are flat.

A majority of economists polled by Reuters think the U.S. Federal Reserve will raise interest rates at least twice more in coming months, with the risk they go higher still, and they see no cut by year-end.

European earnings continue to trickle through, as does the impact of inflation on companies' performance. Norwegian aluminium producer Norsk Hydro said inflationary pressures in 2023 are likely to subside, though the outlook is "unpredictable", as it posted a bigger-than-expected fall in fourth-quarter core profit.

Meanwhile, holiday group TUI, said on Tuesday it was seeing a positive travel recovery trend for the upcoming summer season.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.